Status:
COMPLETED
Erector Spinae Block Versus PECS Block Type II for Breast Surgeries
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Analgesia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this randomized, controlled prospective study is to compare the analgesic effect of US-guided ESP block versus PECs block in patients undergoing breast surgery for breast cancer in the ...
Detailed Description
This prospective, randomized controlled trial will include 30 adult female patients below 65 years of age scheduled for surgery for breast cancer. Inclusion criteria will include also American Society...
Eligibility Criteria
Inclusion
- ASA I-II
- Adult patients (\>18 years old)
- Female sex
- Scheduled for breast surgeries at NCI, CU
Exclusion
- Patient's refusal of the study procedures
- Allergy to drugs used in the study
- Patients with chronic pain and chronic use of opioids
- Patients with coagulopathies (INR \> 1.6 or platelets count \< 50,000 cc3)
- Hemodynamically unstable patients (e.g. BP \< 90/60)
- Patients with local or systemic infections concerning intervention sites and septic patients
Key Trial Info
Start Date :
March 19 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04284124
Start Date
March 19 2020
End Date
March 10 2021
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NCI Egypt
Cairo, Egypt, 02002